SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 50.03 Million USD | -51.03% |
| 2021 | 102.17 Million USD | -1.7% |
| 2020 | 103.94 Million USD | 10.86% |
| 2019 | 93.75 Million USD | 77.95% |
| 2018 | 52.68 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 29.61 Million USD | -10.27% |
| 2023 Q1 | 33 Million USD | -34.05% |
| 2023 Q3 | 27.9 Million USD | -5.75% |
| 2022 Q1 | 95.88 Million USD | -6.16% |
| 2022 Q3 | 86.28 Million USD | -6.34% |
| 2022 Q4 | 50.03 Million USD | -42.0% |
| 2022 Q2 | 92.12 Million USD | -3.92% |
| 2022 FY | 50.03 Million USD | -51.03% |
| 2021 Q3 | 110.86 Million USD | 0.0% |
| 2021 FY | 102.17 Million USD | -1.7% |
| 2021 Q4 | 102.17 Million USD | -7.84% |
| 2020 FY | 103.94 Million USD | 10.86% |
| 2019 FY | 93.75 Million USD | 77.95% |
| 2018 FY | 52.68 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -182304.403% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -428.623% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 30.953% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -6086.866% |
| Rebus Holdings, Inc. | 5.24 Million USD | -854.578% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 15.208% |
| Qrons Inc. | 1.48 Million USD | -3261.225% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -3980.776% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 33.21% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -111854.09% |
| Skye Bioscience, Inc. | 14.07 Million USD | -255.587% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 6.127% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -422.218% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -11769.734% |
| Intellipharmaceutics International Inc. | 12 Million USD | -316.687% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -1199.234% |
| Mesoblast Limited | 188.44 Million USD | 73.446% |
| Marizyme, Inc. | 26.67 Million USD | -87.583% |
| Genus plc | 485 Million USD | 89.683% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -756.448% |
| Pharming Group N.V. | 244.07 Million USD | 79.498% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -2389.341% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -1888.572% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -1216.816% |
| ContraFect Corporation | 32.53 Million USD | -53.819% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -2425.554% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -1207.304% |
| IMV Inc. | 37.93 Million USD | -31.915% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -324.844% |
| MultiCell Technologies, Inc. | 1617.67 USD | -3093176.132% |
| ONE Bio Corp. | 27.49 Million USD | -81.988% |
| Accustem Sciences Inc. | 1.07 Million USD | -4536.508% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 35.364% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -2265.833% |
| Q BioMed Inc. | 8.13 Million USD | -515.263% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 39.665% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -872.38% |
| Biomind Labs Inc. | 1.49 Million USD | -3239.023% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 57.852% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -453.394% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -171.901% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -3389.808% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -35115.173% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -24780.666% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -770.876% |
| GB Sciences, Inc. | 5.41 Million USD | -823.645% |
| Alpha Cognition Inc. | 7.16 Million USD | -598.403% |
| HST Global, Inc. | 593.59 Thousand USD | -8329.85% |
| CSL Limited | 18.62 Billion USD | 99.731% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -3873.894% |
| Halberd Corporation | 728.71 Thousand USD | -6766.707% |
| Enzolytics Inc. | 365.26 Million USD | 86.301% |
| Agentix Corp. | 2.51 Million USD | -1893.145% |
| Resverlogix Corp. | 67.39 Million USD | 25.754% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -5866.03% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 88.754% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -2819.428% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -102.21% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -320.386% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -1265.26% |
| AVAX Technologies, Inc. | 3.99 Million USD | -1152.934% |
| Zenith Capital Corp. | 27.56 Thousand USD | -181404.588% |
| Genscript Biotech Corporation | 1.32 Billion USD | 96.226% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -20867.174% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -1239.981% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -7249.662% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -1745.34% |
| Kadimastem Ltd | 3.5 Million USD | -1327.7% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -74664.302% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 0.448% |
| BioStem Technologies, Inc. | 15.9 Million USD | -214.618% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -10668.046% |
| LadRx Corporation | 2.2 Million USD | -2173.954% |
| Cell Source, Inc. | 15.8 Million USD | -216.568% |
| Regen BioPharma, Inc. | 5.45 Million USD | -816.866% |
| Regen BioPharma, Inc. | 5.45 Million USD | -816.866% |
| NovAccess Global Inc. | 7.86 Million USD | -536.569% |
| Affymax, Inc. | 8.87 Million USD | -464.074% |
| Itoco Inc. | 1.65 Million USD | -2926.886% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -2339.065% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -727.228% |
| Mobile Lads Corp. | 1.31 Million USD | -3709.601% |
| CytoDyn Inc. | 127.89 Million USD | 60.875% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -119613.39% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -3094.569% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -353.035% |
| SYBLEU INC | 681.41 Thousand USD | -7243.417% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -720.055% |
| International Stem Cell Corporation | 5.27 Million USD | -848.247% |
| Bioxytran, Inc. | 3.24 Million USD | -1439.898% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -7895.89% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -983.77% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -22.058% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -124.743% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -2370.59% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -813.454% |
| Neutra Corp. | 973.52 Thousand USD | -5039.96% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -72.459% |
| PureTech Health plc | 125.58 Million USD | 60.155% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -1231.843% |
| IXICO plc | 1.9 Million USD | -2533.227% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -143.748% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 51.571% |
| CSL Limited | 18.62 Billion USD | 99.731% |
| Cellectis S.A. | 249.36 Million USD | 79.934% |